IMAGE: This is E. John Wherry, PhD. view more
Credit: Penn Medicine
PHILADELPHIA – E. John Wherry, PhD, co-leader of the Abramson Cancer Center’s Immunobiology Program and director of the Institute for Immunology at the University of Pennsylvania, has received a Phillip A. Sharp Innovation in Collaboration Award from Stand Up To Cancer (SU2C), the non-profit organization established by film and media leaders to support collaborative cancer research and increase awareness about cancer prevention.
Wherry, the Richard and Barbara Schiffrin President’s Distinguished Professor of Microbiology in Penn’s Perelman School of Medicine, and Matthew Hellmann, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, comprise one of five teams to receive $1.25 million to cross institutional lines and collaborate on new research projects. The members of the five teams are all part of the SU2C research community. In selecting the winning projects, the organization placed an emphasis on projects that involved SU2C-funded researchers with different skill sets.
Under the award, Wherry and Hellmann will seek to improve reinvigoration of exhausted T cells, which are white blood cells that are part of the immune system. The “T” stands for “thymus” – the organ in which these cells mature, as opposed
Article originally posted at